<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="135265">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01340742</url>
  </required_header>
  <id_info>
    <org_study_id>R-10-132</org_study_id>
    <secondary_id>16811</secondary_id>
    <nct_id>NCT01340742</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Preconditioning Before Abdominal Surgery</brief_title>
  <official_title>Remote Ischemic Preconditioning Before Abdominal Surgery and the Prevalence of Perioperative Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lawson Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lawson Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Major abdominal surgeries are associated with perioperative cardiac morbidity of up to 10%.

      Ischemic preconditioning may have a protective effect. The purpose of this study is to find
      out remote ischemic conditioning by inflating a blood pressure cuff on the arm will have a
      protective effect.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular Events: incidence of MI, TIA/stroke, death in both groups</measure>
    <time_frame>One week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal function deterioration in the first week after surgery</measure>
    <time_frame>One week</time_frame>
    <description>Baseline Creatinine levels will be compared to the highest creatinine levels noted in the first 7 days of hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Perioperative/Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm remote preconditioning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote Ischemic Pre-conditioning</intervention_name>
    <description>Cuff placed on arm. Three 5- minute cycles of blood pressure cuff inflation: cuff is inflated to 200 mm Hg for 5 minutes followed by a 5-minute deflation (reperfusion.)</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Cuff placed on arm uninflated for 30 minutes.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing abdominal surgery:large bowel, pancreatic and hepatic surgery

        Exclusion Criteria:

          -  Chronic inflammatory disease.

          -  Glyburide use before surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronit Lavi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lawson Health Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronit Lavi, MD</last_name>
      <phone>519-685-8500</phone>
      <phone_ext>33384</phone_ext>
      <email>ronit.lavi@lhsc.on.ca</email>
    </contact>
    <investigator>
      <last_name>Ronit Lavi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <lastchanged_date>June 29, 2011</lastchanged_date>
  <firstreceived_date>February 14, 2011</firstreceived_date>
  <responsible_party>
    <name_title>Dr. Ronit Lavi</name_title>
    <organization>Lawson Health Research Institute</organization>
  </responsible_party>
  <keyword>Remote ischemic preconditioning</keyword>
  <keyword>Abdominal surgery</keyword>
  <keyword>Perioperative complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
